GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (MEX:AXNX) » Definitions » Accumulated other comprehensive income (loss)

Axonics (MEX:AXNX) Accumulated other comprehensive income (loss) : MXN-282 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Axonics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Axonics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was MXN-282 Mil.

Axonics's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (MXN-427 Mil) to Dec. 2023 (MXN-269 Mil) but then declined from Dec. 2023 (MXN-269 Mil) to Mar. 2024 (MXN-282 Mil).

Axonics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (MXN-135 Mil) to Dec. 2022 (MXN-490 Mil) but then increased from Dec. 2022 (MXN-490 Mil) to Dec. 2023 (MXN-269 Mil).

Axonics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Axonics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axonics Accumulated other comprehensive income (loss) Chart

Axonics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial -8.07 -8.57 -134.57 -490.27 -269.33

Axonics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -397.92 -314.18 -426.96 -269.33 -282.45

Axonics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Axonics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Axonics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Axonics (MEX:AXNX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (MEX:AXNX) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
LIVN IRTC ITGR IART CNMD PACB GKOS NARI INMD NVCR ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
AXNX:USA
Address
26 Technology Drive, Irvine, CA, USA, 92618
Website
https://www.axonics.com
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.